Stanolone (DHT) Oil Steroids Injectable 50mg/ml

Description

Stanolone DHT Base Injectable Androgen Research

How It Works

The pharmacology of Stanolone DHT Oil is defined by its structural configuration as a 5α-reduced steroid, which precludes its conversion into estrogenic metabolites via the aromatase enzyme. Stanolone binds to the nuclear androgen receptor with an affinity approximately 3 to 10 times higher than that of testosterone. DHT-mediated signaling activates myogenic gene transcription by promoting the translocation of the receptor complex into the nucleus. Non-aromatizable androgens modulate central nervous system output by interacting with GABAergic and glutamatergic pathways. Binding kinetics show a high dissociation rate, yet the oil-depot delivery system extends the terminal half-life to approximately 12 to 18 hours (±1.5 hours). Quantitatively, Stanolone possesses a binding affinity (Ki) of ~0.5 nM for the AR. Unlike Mesterolone (Proviron), which is 1-methylated to improve oral bioavailability, parenteral Stanolone provides the unmodified DHT molecule for direct systemic saturation.

Chemical Properties

• CAS Number: 521-18-6
• Molecular Formula: C19H30O2
• Molecular Weight: 290.44 g/mol
• Appearance: Clear, colorless to pale golden viscous lipid solution
• Purity: >99% confirmed via HPLC-UV and GC/MS
• Solubility: Optimized in organic carrier lipids including Ethyl Oleate and Grapeseed Oil

Experimental Outcomes

• Neurological Muscle Drive: Experimental data suggests a profound increase in neurological force production and central nervous system output during high-intensity training.
• Enhanced Muscle Density: Based on community feedback, effects include significant increases in muscular hardness and ‘dryness’ due to zero fluid retention.
• Lipolysis Modulation: Study data demonstrates accelerated subcutaneous fat loss through androgen-receptor-mediated down-regulation of lipid storage.
• Strength Metrics: The typical user-reported experience involves a rapid upward trajectory in maximal strength and explosiveness within 7 to 10 days.
• Libido Regulation: Observed effects in research models include the stabilization of androgen-dependent drive without estrogenic interference.

About This Compound

Stanolone (Dihydrotestosterone) is a potent synthetic vitamer of the endogenous 5α-reduced testosterone metabolite, functioning as the primary ligand for the nuclear androgen receptor in peripheral tissues. Stanolone DHT Oil facilitates direct androgenic signaling without the metabolic requirement for enzymatic reduction. Researchers prioritize this oil-based parenteral system for studying acute myogenic regulatory factors and the modulation of central nervous system (CNS) output in advanced biological models.
Summary:
Stanolone DHT Oil remains a high-precision research tool for studying pure androgenic signaling and CNS-mediated force production with unmatched receptor affinity.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.